Cathie Wood says her firm is testing a more aggressive strategy that would be 'Ark on steroids'
Ark Invest's Cathie Wood said her firm is internally testing a fund that bets against major stocks in the benchmarks and would be "Ark on steroids."
More @ CNBC...
